FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2219580342> ?p ?o ?g. }

• W2219580342 endingPage "712" @default.
• W2219580342 startingPage "677" @default.
• W2219580342 abstract "An accelerating trend in the pharmaceutical industry is the use of plastic components in systems used to produce an active pharmaceutical ingredient or a finished drug product. If the active pharmaceutical ingredient, the finished drug product, or any solution used to generate them (for example, a process stream such as media, buffers, eluents, and the like) is contacted by a plastic component at any time during the production process, substances leached from the component may accumulate in the active pharmaceutical ingredient or finished drug product, affecting its safety and/or efficacy. In this article the author develops and justifies a semi-quantitative risk evaluation matrix that is used to determine the amount and rigor of component testing necessary and appropriate to establish that the component is chemically suitable for its intended use. By considering key properties of the component, the contact medium, the contact conditions, and the active pharmaceutical ingredient's or finished drug product's clinical conditions of use, use of the risk evaluation matrix produces a risk score whose magnitude reflects the accumulated risk that the component will interact with the contact solution to such an extent that component-related extractables will accumulate in the active pharmaceutical ingredient or finished drug product as leachables at levels sufficiently high to adversely affect user safety. The magnitude of the risk score establishes the amount and rigor of the testing that is required to select and qualify the component, and such testing is broadly grouped into three categories: baseline assessment, general testing, and full testing (extractables profiling).Production suites used to generate pharmaceuticals can include plastic components. It is possible that substances in the components could leach into manufacturing solutions and accumulate in the pharmaceutical product. In this article the author develops and justifies a semi-quantitative risk evaluation matrix that can be used to determine the amount and rigor of component testing that may be necessary and appropriate to establish that the component is suitable for its intended use. Use of the risk evaluation matrix allows a user of a component to determine the type and amount of testing that should be performed to establish the patient safety risk associated with using that component in order to manufacture an active pharmaceutical ingredient or a finished drug product." @default.
• W2219580342 created "2016-06-24" @default.
• W2219580342 creator A5042321180 @default.
• W2219580342 date "2015-11-01" @default.
• W2219580342 modified "2023-09-27" @default.
• W2219580342 title "Development and Justification of a Risk Evaluation Matrix To Guide Chemical Testing Necessary To Select and Qualify Plastic Components Used in Production Systems for Pharmaceutical Products" @default.
• W2219580342 cites W1807537407 @default.
• W2219580342 cites W1821162804 @default.
• W2219580342 cites W1877383498 @default.
• W2219580342 cites W1888042112 @default.
• W2219580342 cites W1950250567 @default.
• W2219580342 cites W198425594 @default.
• W2219580342 cites W1993844832 @default.
• W2219580342 cites W2009929392 @default.
• W2219580342 cites W2010512798 @default.
• W2219580342 cites W2011651943 @default.
• W2219580342 cites W2022296588 @default.
• W2219580342 cites W2030242631 @default.
• W2219580342 cites W2035004110 @default.
• W2219580342 cites W2057415115 @default.
• W2219580342 cites W2067714603 @default.
• W2219580342 cites W2078172351 @default.
• W2219580342 cites W2114321773 @default.
• W2219580342 cites W2128456909 @default.
• W2219580342 cites W2134431038 @default.
• W2219580342 cites W2188346842 @default.
• W2219580342 cites W2194319401 @default.
• W2219580342 cites W2375408415 @default.
• W2219580342 cites W2504125666 @default.
• W2219580342 cites W2517468184 @default.
• W2219580342 doi "https://doi.org/10.5731/pdajpst.2015.01077" @default.
• W2219580342 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26659101" @default.
• W2219580342 hasPublicationYear "2015" @default.
• W2219580342 type Work @default.
• W2219580342 sameAs 2219580342 @default.
• W2219580342 citedByCount "4" @default.
• W2219580342 countsByYear W22195803422020 @default.
• W2219580342 countsByYear W22195803422021 @default.
• W2219580342 countsByYear W22195803422022 @default.
• W2219580342 crossrefType "journal-article" @default.
• W2219580342 hasAuthorship W2219580342A5042321180 @default.
• W2219580342 hasConcept C111919701 @default.
• W2219580342 hasConcept C112930515 @default.
• W2219580342 hasConcept C121332964 @default.
• W2219580342 hasConcept C127413603 @default.
• W2219580342 hasConcept C139719470 @default.
• W2219580342 hasConcept C144133560 @default.
• W2219580342 hasConcept C162324750 @default.
• W2219580342 hasConcept C162853370 @default.
• W2219580342 hasConcept C168167062 @default.
• W2219580342 hasConcept C183696295 @default.
• W2219580342 hasConcept C185592680 @default.
• W2219580342 hasConcept C19351080 @default.
• W2219580342 hasConcept C200601418 @default.
• W2219580342 hasConcept C21880701 @default.
• W2219580342 hasConcept C2524010 @default.
• W2219580342 hasConcept C2778348673 @default.
• W2219580342 hasConcept C2779652045 @default.
• W2219580342 hasConcept C2780589914 @default.
• W2219580342 hasConcept C31903555 @default.
• W2219580342 hasConcept C33923547 @default.
• W2219580342 hasConcept C41008148 @default.
• W2219580342 hasConcept C45904493 @default.
• W2219580342 hasConcept C71924100 @default.
• W2219580342 hasConcept C77281830 @default.
• W2219580342 hasConcept C90673727 @default.
• W2219580342 hasConcept C97355855 @default.
• W2219580342 hasConcept C98045186 @default.
• W2219580342 hasConcept C98274493 @default.
• W2219580342 hasConceptScore W2219580342C111919701 @default.
• W2219580342 hasConceptScore W2219580342C112930515 @default.
• W2219580342 hasConceptScore W2219580342C121332964 @default.
• W2219580342 hasConceptScore W2219580342C127413603 @default.
• W2219580342 hasConceptScore W2219580342C139719470 @default.
• W2219580342 hasConceptScore W2219580342C144133560 @default.
• W2219580342 hasConceptScore W2219580342C162324750 @default.
• W2219580342 hasConceptScore W2219580342C162853370 @default.
• W2219580342 hasConceptScore W2219580342C168167062 @default.
• W2219580342 hasConceptScore W2219580342C183696295 @default.
• W2219580342 hasConceptScore W2219580342C185592680 @default.
• W2219580342 hasConceptScore W2219580342C19351080 @default.
• W2219580342 hasConceptScore W2219580342C200601418 @default.
• W2219580342 hasConceptScore W2219580342C21880701 @default.
• W2219580342 hasConceptScore W2219580342C2524010 @default.
• W2219580342 hasConceptScore W2219580342C2778348673 @default.
• W2219580342 hasConceptScore W2219580342C2779652045 @default.
• W2219580342 hasConceptScore W2219580342C2780589914 @default.
• W2219580342 hasConceptScore W2219580342C31903555 @default.
• W2219580342 hasConceptScore W2219580342C33923547 @default.
• W2219580342 hasConceptScore W2219580342C41008148 @default.
• W2219580342 hasConceptScore W2219580342C45904493 @default.
• W2219580342 hasConceptScore W2219580342C71924100 @default.
• W2219580342 hasConceptScore W2219580342C77281830 @default.
• W2219580342 hasConceptScore W2219580342C90673727 @default.
• W2219580342 hasConceptScore W2219580342C97355855 @default.
• W2219580342 hasConceptScore W2219580342C98045186 @default.
• W2219580342 hasConceptScore W2219580342C98274493 @default.
• W2219580342 hasIssue "6" @default.

• next